Erma J. Gill is currently pursuing her Ph.D. degree in drug development from Nova Southeastern University (NSU), Fort Lauderdale, FL. She received a master’s degree from Nova Southeastern University in 2023 followed by Ph.D. studies in Drug Development there (2023–2026). She obtained her Doctor of Pharmacy degree from Sarhad University of Information & Technology, Peshawar Pakistan in 2014. She initially worked as an industrial pharmacist for Libra Pharmaceuticals, Peshawar, Pakistan before relocating to the United States in 2015. Upon settling in the U.S., she began her career as a pharmacy technician at CVS in 2016 and since has been employed as a pharmacist intern with the same company. She is also working as a teaching assistant (part-time) at NSU. Her research expertise lies in pharmaceutical sciences, drug development, and formulations.
Erma J. Gill is currently pursuing her Ph.D. degree in drug development from Nova Southeastern University (NSU), Fort Lauderdale, FL. She received a master’s degree from Nova Southeastern University in 2023 followed by Ph.D. studies in Drug Development there (2023–2026). She obtained her Doctor of Pharmacy degree from Sarhad University of Information & Technology, Peshawar Pakistan in 2014. She initially worked as an industrial pharmacist for Libra Pharmaceuticals, Peshawar, Pakistan before relocating to the United States in 2015. Upon settling in the U.S., she began her career as a pharmacy technician at CVS in 2016 and since has been employed as a pharmacist intern with the same company. She is also working as a teaching assistant (part-time) at NSU. Her research expertise lies in pharmaceutical sciences, drug development, and formulations.